Lazkani Mohamad, Yerasi Charan, Prakash Sheena, Pershad Ashish, Fang Kenith
University of Colorado Health, Medical Center of the Rockies, Loveland, Colorado.
St. Joseph's Medical Center, Phoenix, Arizona.
J Card Surg. 2018 Dec;33(12):808-817. doi: 10.1111/jocs.13938. Epub 2018 Dec 12.
Permanent pacemaker (PPM) implantation and paravalvular leak (PVL) rates after sutureless aortic valve replacement (SuAVR) vary widely. The aim of this meta-analysis was to examine the incidence of new PPM implantation and PVL after SuAVR.
Studies evaluating PPM implantation and PVL rates after SuAVR were searched in Medline/PubMed, Ovid Journals, Clinicaltrials.gov, Cochrane central register of controlled trials and database. Studies with a sample size ≥10 were included in this analysis. Pooled proportions were calculated using both the fixed and random-effects models. The heterogeneity among studies was tested using I statistic. The study design was written in accordance with PRISMA guidelines.
Thirty studies involving 3993 patients with a median follow-up of 12 months were included. The median age was 77 years and males constituted 50%. There was a history of stroke and coronary artery disease in 6% and 31% of the population. Pooled proportions demonstrate a cumulative postoperative PPM rate of 8.5% (95% confidence interval [CI] 7.6-9.5%, I = 68.8%) and the overall rate of any PVL was 4.2% (95%CI 3.4-5%, I = 76.1%) across all major SuAVR devices. The rate of severe PVL was only 0.4% (95%CI 0.2-0.7%, I = 0%) at discharge and 0.5% (95%CI 0.2-0.9%, I = 0%) at 12 months.
In SuAVR prostheses implanted in this meta-analysis, the postoperative permanent pacemaker rate was higher (8.5%) than reported for non-SuAVR prosthesis. While the overall PVL rate was 4.2%, the incidence of severe PVL was only 0.4% at discharge and remained stable at 0.5% at 12 months.
无缝合主动脉瓣置换术(SuAVR)后永久性起搏器(PPM)植入率和瓣周漏(PVL)发生率差异很大。本荟萃分析的目的是研究SuAVR后新的PPM植入和PVL的发生率。
在Medline/PubMed、Ovid期刊、Clinicaltrials.gov、Cochrane对照试验中央注册库和数据库中检索评估SuAVR后PPM植入率和PVL发生率的研究。样本量≥10的研究纳入本分析。使用固定效应模型和随机效应模型计算合并比例。使用I统计量检验研究间的异质性。研究设计按照PRISMA指南撰写。
纳入30项研究,共3993例患者,中位随访时间为12个月。中位年龄为77岁,男性占50%。6%的人群有中风病史,31%有冠状动脉疾病史。合并比例显示,所有主要SuAVR装置术后PPM累积发生率为8.5%(95%置信区间[CI]7.6 - 9.5%,I = 68.8%),任何PVL的总体发生率为4.2%(95%CI 3.4 - 5%,I = 76.1%)。出院时严重PVL发生率仅为0.4%(95%CI 0.2 - 0.7%,I = 0%),12个月时为0.5%(95%CI 0.2 - 0.9%,I = 0%)。
在本荟萃分析中植入的SuAVR假体中,术后永久性起搏器发生率(8.5%)高于非SuAVR假体报道的发生率。虽然总体PVL发生率为4.2%,但出院时严重PVL发生率仅为0.4%,12个月时稳定在0.5%。